a a Trends & Opportunities
in Early Growth Markets
    MicroRNA Analysis
 
Life Science
Dashboard™
 
  2008 Dashboards:
    Gene Expression Profiling
    Gene Silencing
    Nucleic Acid Separation
  2007 Dashboards:
  Nucleic Acid Purification
    Nucleic Acid Amplification
    Transfection
    Cell Culture
    Gene Silencing
    Gene Expression Profiling
 
  Life Science Marketing
Series
  Subscribe
  Privacy Policy
Publications : 2007 Nucleic Acid Purification Dashboard
Series 1
Catalog number: 0701NAP
Publication date: January 2007
Company-wide electronic copy: $3,000

Please enquire about single-user* electronic copy pricing
* single-user pricing is intended for small companies, of 40 or less employees, to access The Life Science Dashboard. Please order these copies directly with Percepta Associates.
 

Table of Contents

Figures and Tables
Executive Summary
Key Findings and Implications
Nucleic Acid Purification Dashboard
Market Opportunity Matrix
Survey Methodology
Survey Invitation Text
Respondent Demographics
Frequency of Performance of Molecular Biology Techniques
Frequency of Performance of Nucleic Acid Purification
Reaction Throughput and Market Growth Rates
Respondent’s Stated Price per Reaction
Total Market Size, Market Segment Sizes and Total Market Growth Rate
Market Shares by Segment (Share of Mention)
Market Shares for Plasmid Purification Products
Market Shares for Genomic DNA Purification Products
Market Shares for RNA Purification Products
Customer Satisfaction and Interest In Switching Suppliers
Product Features That Influence Purchasing Decisions
Primary and Secondary Downstream Applications
Desired Changes to Nucleic Acid Purification Products
Survey Questionnaire

Figures and Tables

Figure 1: Respondent’s Place of Employment
Figure 2: Respondent’s Country/Region
Figure 3: Respondent’s Job Title
Figure 4: Respondent’s Areas of Expertise/Specialization
Figure 5: Number of Employees in Respondent’s Laboratories
Figure 6: Percentage of Respondents Performing Various Techniques at
                 Least a Few Times per Year
Figure 7: Percentage of Respondents Performing Nucleic Acid Purification
Figure 8: Percentage of Respondents Performing Various Nucleic Acid
                 Purification Techniques at Least a Few Times per Year
Figure 9: Percentage of Respondents Performing Plasmid Minipreps
Figure 10: Percentage of Respondents Performing Plasmid Midipreps
Figure 11: Percentage of Respondents Performing Plasmid Maxipreps
Figure 12: Percentage of Respondents Performing Genomic DNA
                    Isolation from Cells or Tissues
Figure 13: Percentage of Respondents Performing Genomic DNA Isolation
                    from Whole Blood
Figure 14: Percentage of Respondents Performing Total RNA Isolation
                    from Cells or Tissues
Figure 15: Percentage of Respondents Performing Total RNA Isolation
                    from Whole Blood
Figure 16: Percentage of Respondents Performing mRNA Isolation
Figure 17: Percentage of Respondents Performing miRNA (micro RNA) Isolation
Figure 18: Respondent’s Primary Supplier for Plasmid Miniprep
                    Purification Products
Figure 19: Respondent’s Primary Supplier for Plasmid Miniprep Purification
                    Products by Region
Figure 20: Respondent’s Primary Supplier for Plasmid Miniprep
                    Purification Products by Organization Type
Figure 21: Respondent’s Primary Supplier for Plasmid Midiprep
                    Purification Products
Figure 22: Respondent’s Primary Supplier for Plasmid Midiprep
                    Purification Products by Region
Figure 23: Respondent’s Primary Supplier for Plasmid Midiprep
                    Purification Products by Organization Type
Figure 24: Respondent’s Primary Supplier for Plasmid Maxiprep
                    Purification Products
Figure 25: Respondent’s Primary Supplier for Plasmid Maxiprep
                    Purification Products by Region
Figure 26: Respondent’s Primary Supplier for Plasmid Maxiprep
                    Purification Products by Organization Type
Figure 27: Respondent’s Primary Supplier for Purifying Genomic DNA from
                    Cells or Tissues
Figure 28: Respondent’s Primary Supplier for Purifying Genomic DNA from
                    Cells or Tissues by Region
Figure 29: Respondent’s Primary Supplier for Purifying Genomic DNA from
                    Cells or Tissues by Organization Type
Figure 30: Respondent’s Primary Supplier for Purifying Genomic DNA
                    from Blood
Figure 31: Respondent’s Primary Supplier for Purifying Genomic DNA
                    from Blood by Region
Figure 32: Respondent’s Primary Supplier for Purifying Genomic DNA
                    from Blood by Organization Type
Figure 33: Respondent’s Primary Supplier for Purifying Total RNA from
                    Cells or Tissues
Figure 34: Respondent’s Primary Supplier for Purifying Total RNA from
                    Cells or Tissues by Region
Figure 35: Respondent’s Primary Supplier for Purifying Total RNA from
                    Cells or Tissues by Organization Type
Figure 36: Respondent’s Primary Supplier for Purifying Total RNA from Blood
Figure 37: Respondent’s Primary Supplier for Purifying Total RNA from
                    Blood by Region
Figure 38: Respondent’s Primary Supplier for Purifying Total RNA from
                    Blood by Organization Type
Figure 39: Respondent’s Primary Supplier for Purifying mRNA
Figure 40: Respondent’s Primary Supplier for Purifying mRNA by Region
Figure 41: Respondent’s Primary Supplier for Purifying mRNA by
                   Organization Type
Figure 42: Respondent’s Primary Supplier for Purifying miRNA (Micro RNA)
Figure 43: Respondent’s Primary Supplier for Purifying miRNA (Micro RNA)
                    by Region
Figure 44: Respondent’s Primary Supplier for Purifying miRNA (Micro RNA)
                    by Organization Type
Figure 45: Percentage of Respondents That Have Switched Suppliers in
                    the Last Six Months
Figure 46: Most Important Features of Nucleic Acid Purification Products
Figure 47: Respondent’s Primary Application for Purified Plasmid DNA
Figure 48: Respondent’s Primary and Secondary Applications for Purified
                    Plasmid DNA
Figure 49: Respondent’s Primary Application for Purified Genomic DNA
Figure 50: Respondent’s Primary and Secondary Applications for Purified
                   Genomic DNA
Figure 51: Respondent’s Primary Application for Purified Total RNA
Figure 52: Respondent’s Primary and Secondary Applications for Purified
                    Total RNA
Figure 53: Respondent’s Primary Application for Purified mRNA
Figure 54: Respondent’s Primary and Secondary Applications for Purified mRNA
Figure 55: Respondent’s Primary Application for Purified miRNA (Micro RNA)

Table 1: Frequency of Performance of Various Techniques
Table 2: Frequency of Co-Performance of Various Molecular Biology Techniques
Table 3: Frequency of Performance of Various Nucleic Acid Purification Methods
Table 4: Frequency of Co-Performance of Molecular Biology Techniques with
                Nucleic Acid Purification Methods
Table 5: Frequency of Co-Performance of Nucleic Acid Purification Methods with
                Molecular Biology Techniques
Table 6: Median and Average Monthly Throughput for Nucleic Acid
                Purification Products
Table 7: Percentage of Respondents Performing Various Numbers of
                Purification Reactions Per Month for Nucleic Acid Purification Products
Table 8: Projected Growth in the Performance of Various Nucleic Acid
                Purification Techniques
Table 9: Median and Average Price Per Prep for Nucleic Acid
                Purification Products
Table 10: Market Share Leaders for Plasmid DNA Purification Products
Table 11: Market Share Leaders for Genomic DNA Purification Products
Table 12: Market Share Leaders for RNA Purification Products
Table 13: Percentage of Respondents Satisfied with Various Nucleic Acid
                  Purification Techniques & Reasons for Dissatisfaction

Site Map | Privacy Policy | © 2005-2008 Percepta Associates Inc.